Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial.

Davenport ML, Crowe BJ, Travers SH, Rubin K, Ross JL, Fechner PY, Gunther DF, Liu C, Geffner ME, Thrailkill K, Huseman C, Zagar AJ, Quigley CA.

J Clin Endocrinol Metab. 2007 Sep;92(9):3406-16. Epub 2007 Jun 26.

PMID:
17595258
2.

Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial.

Blum WF, Crowe BJ, Quigley CA, Jung H, Cao D, Ross JL, Braun L, Rappold G; SHOX Study Group.

J Clin Endocrinol Metab. 2007 Jan;92(1):219-28. Epub 2006 Oct 17.

PMID:
17047016
3.

Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.

Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.

Clin Endocrinol (Oxf). 2006 Sep;65(3):310-9.

PMID:
16918949
4.

The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.

Binder G, Baur F, Schweizer R, Ranke MB.

J Clin Endocrinol Metab. 2006 Feb;91(2):659-64. Epub 2005 Nov 15.

PMID:
16291706
5.
7.

Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.

van Teunenbroek A, de Muinck Keizer-Schrama SM, Stijnen T, Jansen M, Otten BJ, Delemarre-van de Waal HA, Vulsma T, Wit JM, Rouwé CW, Reeser HM, Gosen JJ, Rongen-Westerlaken C, Drop SL.

J Clin Endocrinol Metab. 1996 Nov;81(11):4013-21.

PMID:
8923853
8.

Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.

Tillmann V, Patel L, Gill MS, Whatmore AJ, Price DA, Kibirige MS, Wales JK, Clayton PE.

Clin Endocrinol (Oxf). 2000 Sep;53(3):329-36.

PMID:
10971450
9.

Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.

de Zegher F, Du Caju MV, Heinrichs C, Maes M, De Schepper J, Craen M, Vanweser K, Malvaux P, Rosenfeld RG.

J Clin Endocrinol Metab. 1999 May;84(5):1558-61.

PMID:
10323379
10.

Growth hormone treatment does not affect incidences of middle ear disease or hearing loss in infants and toddlers with Turner syndrome.

Davenport ML, Roush J, Liu C, Zagar AJ, Eugster E, Travers S, Fechner PY, Quigley CA.

Horm Res Paediatr. 2010;74(1):23-32. doi: 10.1159/000313964. Epub 2010 Apr 27.

11.

Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial.

Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Massa GG, Rouwe CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL.

J Clin Endocrinol Metab. 1999 Dec;84(12):4607-12.

PMID:
10599727
12.

Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.

van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Stokvis-Brantsma WH, Rouwé CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL.

J Clin Endocrinol Metab. 2003 Mar;88(3):1119-25.

PMID:
12629094
13.

Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.

Blum WF, Cao D, Hesse V, Fricke-Otto S, Ross JL, Jones C, Quigley CA, Binder G.

Horm Res. 2009;71(3):167-72. doi: 10.1159/000197874. Epub 2009 Feb 3.

PMID:
19188742
14.

Efficacy and safety of Valtropin in the treatment of short stature in girls with Turner's syndrome.

Peterkova V, Savoy C, Bezlepkina O, Ivanov A, Orlova E, Nagaeva E, Kim J, Lee YP, Saenger PH, Stanhope R.

J Pediatr Endocrinol Metab. 2004 Oct;17(10):1429-34.

PMID:
15526722
15.

Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height.

Quigley CA, Crowe BJ, Anglin DG, Chipman JJ.

J Clin Endocrinol Metab. 2002 May;87(5):2033-41.

PMID:
11994337
16.

Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study.

Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard AM, Rosenfeld RG; American Norditropin Study Group.

J Clin Endocrinol Metab. 2007 Jul;92(7):2480-6. Epub 2007 Mar 13.

PMID:
17356043
17.

Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.

Van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A.

J Clin Endocrinol Metab. 2003 Aug;88(8):3584-90.

PMID:
12915640
18.

An observational study of the effectiveness and safety of growth hormone (Humatrope(®)) treatment in Japanese children with growth hormone deficiency or Turner syndrome.

Tai S, Tanaka T, Hasegawa T, Ozono K, Tanaka H, Kanzaki S, Yokoya S, Fujieda K, Chihara K, Seino Y.

Endocr J. 2013;60(1):57-64. Epub 2012 Oct 20.

19.

Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.

Gravholt CH, Naeraa RW, Brixen K, Kastrup KW, Mosekilde L, Jørgensen JO, Christiansen JS.

Pediatrics. 2002 Nov;110(5):889-96.

PMID:
12415026
20.
Items per page

Supplemental Content

Write to the Help Desk